secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2026-06-18T20:05:38+00:00
Accession:  0001193125-26-275811
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Mirum Pharma annual meeting: all director nominees elected, auditor ratified, say-on-pay approved
--------------------------------------------------------------------------------

- Stockholders elected Lon Cardon, William Fairey, and Timothy Walbert as Class I directors with 39.6M, 40.3M, and 32.3M votes for, respectively.
- Ratification of Ernst & Young as independent auditor for FY 2026 passed with 49.99M votes for, 5,674 against.
- Advisory vote on executive compensation approved with 44.5M votes for, 1.87M against, and 3.6M broker non-votes.
- As of record date April 20, 2026, 60,977,841 shares were outstanding and entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000119312526275811/0001193125-26-275811-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000119312526275811/d74563d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-275811

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer